This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Jim Cramer Says Buy Allergan Over Pfizer and Predicts Google Is Headed to $800

Jim Cramer, portfolio manager of the TheStreet's Action Alerts PLUS, said based on valuation investors should buy Allergan over Pfizer.

Jim Cramer Is Watching GameStop's Q3 Earnings Results Monday

TheStreet's Jim Cramer is keeping an eye on GameStop (GME) Monday when the retailer releases it third quarter earnings results before the opening bell.

Jim Cramer Says Google Is Going to $800, Buy Allergan Over Pfizer

TheStreet's Jim Cramer says based on valuation, investors should buy Allergan (AGN) over Pfizer (PFE) because the two are moving closer to an acquisition.

The Allergan-Pfizer Deal Has a Green Light

The Treasury Department's updated rules do not affect it.

Allergan-Pfizer Talks Still Moving Apace

The latest update demonstrates the companies' commitment to the deal despite concerns over Jack Lew's recent statements.

Jim Cramer on Starbucks and Fitbit Wearables

TheStreet's Jim Cramer answers viewer questions from the floor of the New York Stock Exchange.

Jim Cramer Likes Starbucks and Is Sticking With Health and Wellness

TheStreet’s Jim Cramer answers viewer questions on Starbucks (SBUX), Zillow (ZG), Fitbit (FIT), Halliburton (HAL), Baker Hughes (BHI), Whole Foods (WFM) and Hain Celestial (HAIN).

Jim Cramer Is Watching Foot Locker, Abercrombie and Fitch Earnings Friday

TheStreet's Jim Cramer is keeping an eye on Foot Locker (FL) and Abercrombie & Fitch (ANF) Friday when both companies release their latest quarterly earnings before the opening bell.

UnitedHealth Could Be Best of the Bad

The issues it highlighted earlier are industry-wide issues.

Comments Drain Allergan's Gains

Treasury secretary talks of deterring companies' tax inversions.

Page 3 of 1660
Top Rated Stocks Top Rated Funds Top Rated ETFs